Pharmacological inhibition was effective in gastric adenocarcinoma cells without amplification of ERBB2, FGFR2 or MET. Cell growth and mitosis were inhibited, and programmed cell death was initiated in the presence of the plethora of growth and survival factors that are present in untreated FCS. This evidence concerns the gene ERBB2 and gastric adenocarcinoma.